Dr. Rajesh Ponugupati 2016. EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL. Journal of Population Therapeutics and Clinical Pharmacology. 23, 2 (May 2016), 237–246. DOI:https://doi.org/10.53555/am143177.